Brief: Aethlon Medical Receives Second Ethics Committee Approval For Hemopurifier® Cancer Trial
Aug 12 (Reuters) - Aethlon Medical Inc AEMD.O :
* AETHLON MEDICAL RECEIVES SECOND ETHICS COMMITTEE APPROVAL
FOR
HEMOPURIFIER® CANCER TRIAL
* APPROVAL IS VALID FOR ONE YEAR, UNTIL AUGUST 6, 2025
Source text for Eikon: ID:nPn8bTfRra
Further company coverage: AEMD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aethlon Medical
See all newsU.S. STOCKS ON THE MOVE -Nebius, Securitize, Viant Technology
U.S. STOCKS ON THE MOVE -GlobalFoundries, Lucid, Phillips 66
U.S. STOCKS ON THE MOVE-Generac, Jefferies, Applied Digital
U.S. STOCKS ON THE MOVE-Generac, Jefferies, Aethlon Medical
Aethlon Medical skyrockets after merger with North Immunology